Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Umer Raffat is an analyst at Evercore ISI Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/16/2024
Buy Now | Get Alert | ||||||||
---|---|---|---|---|---|---|---|---|---|
07/16/2024 | SYRE | Buy Now | Spyre Therapeutics | $29.74 | — | — | Initiates | → Outperform | Get Alert |
03/08/2024 | AMLX | Buy Now | Amylyx Pharma | $2.38 | — | — | Downgrade | Outperform → In-Line | Get Alert |
02/28/2024 | GUTS | Buy Now | Fractyl Health | $4.54 | — | — | Initiates | → Outperform | Get Alert |
02/16/2024 | RAPT | Buy Now | RAPT Therapeutics | $3.73 | — | — | Initiates | → Outperform | Get Alert |
10/24/2023 | ALKS | Buy Now | Alkermes | $23.70 | — | — | Upgrade | In-Line → Outperform | Get Alert |
06/21/2023 | CNTA | Buy Now | Centessa Pharmaceuticals | $9.54 | — | — | Initiates | → Outperform | Get Alert |
05/18/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.72 | — | — | Upgrade | In-Line → Outperform | Get Alert |
05/11/2023 | PHAT | Buy Now | Phathom Pharmaceuticals | $12.29 | — | — | Upgrade | In-Line → Outperform | Get Alert |
03/07/2023 | MLYS | Buy Now | Mineralys Therapeutics | $14.58 | — | — | Initiates | → Outperform | Get Alert |
11/02/2022 | LEGN | Buy Now | Legend Biotech | $56.18 | — | — | Initiates | → Outperform | Get Alert |
09/13/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | $42.44 | — | — | Initiates | → Outperform | Get Alert |
05/06/2022 | PHAT | Buy Now | Phathom Pharmaceuticals | $12.29 | — | — | Downgrade | Outperform → In-Line | Get Alert |
02/02/2022 | AMLX | Buy Now | Amylyx Pharma | $2.38 | — | — | Initiates | → Outperform | Get Alert |
03/19/2018 | PIRS | Buy Now | Pieris Pharmaceuticals | $7.50 | 73.33% | → $1040 | Initiates | → Outperform | Get Alert |